813P Time to development of central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with vemurafenib (V) + cobimetinib (C): Updated results from the phase III IMspire150 study
| Autor: | K. Lewis, C. Robert, R. Ramella Munhoz, G. Liszkay, L. de la Cruz Merino, J. Olah, P. Queirolo, J. Mackiewicz, H. Li, Q. Zhu, C. Hertig, N. Paranthaman, E.F. McKenna, R. Gutzmer, G. McArthur, P.A. Ascierto |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S917-S918 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.07.939 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|